Abstract
Bombesin-like peptides and their receptors are widely distributed throughout the gut and are potential mitogens for a number of gastrointestinal (GI) cancers. We have analysed the expression of bombesin-like peptides and their receptor subtypes in normal and neoplastic colorectal tissue. Expression was analysed by reverse transcription polymerase chain reaction (RT-PCR) using receptor and ligand subtype-specific primers and then expression localized by in situ hybridization (ISH) with riboprobes synthesized by in vitro transcription of cloned PCR products. Colorectal cancer tissue and matched normal mucosa from 23 patients were studied. Two of these patients had synchronous adenomatous polyps and two had synchronous hepatic metastases which were also studied. An additional two patients with adenomatous polyps were studied along with matched normal mucosa. Gastrin releasing peptide (GRP) receptor and ligand expression was present in all samples but with overall greater expression in the tumour samples. Neuromedin B (NMB) receptor expression was not detectable. NMB ligand was detected in all but one mucosal sample with overall overexpression in the tumour samples. Bombesin receptor subtype 3 (BRS-3) receptor expression was not detectable. These data support the possibility that GRP may be an autocrine growth factor in colorectal cancer. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Benya RV, Takashi K, Pradhan TK, Battey JF and Jensen RT (1995) Expression and characterization of cloned human bombesin receptors. Mol Pharmacol 47: 10–20
Bitar KN and Zhu XX (1993) Expression of bombesin-receptor subtypes and their differential regulation of colonic smooth muscle contraction. Gastroenterology 105: 1672–1680
Cancer Research Campaign (1993). Cancer Research Campaign Factsheets 18.1–18.4, Cancer Research Campaign: London
Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG and Burt RW (1988) Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. New Engl J Med 319: 533–537
Corjay MH, Dobrzannski DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA and Battey JF (1991) Two distinct bombesin receptor subtypes are expressed and functional in human lung cancer carcinoma cells. J Biol Chem 266: 18771–18779
Cuttita F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A and Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823–826
Daly MC, Spindel ER, Giladi E, Grzeschik K and Naylor SL (1991). Proceedings, 11th Annual Int. Human Gene Mapping Meeting [Abstract]
Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA and Battey JF (1993) BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem 268: 5979–5984
Ferris HA, Carroll RE, Lorimer DL and Benya RV (1997) Location and characterisation of the human GRP receptor expressed by gastrointestinal epithelial cells. Peptides 18: 663–672
Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertson H, Stevens J, Spiro L and Robertson M (1991) Identification and characterisation of the familial adenomatous polyposis coli gene. Cell 66: 589–600
Hirai M, Ishizuka J, Hirai A, Bold RJ, Townsend CM, Jr and Thompson JC (1993) Bombesin stimulates intracellular Ca2+mobilization but not proliferation on human colon cancer cells. Life Sci 53: 1859–1865
Jensen RT and Coy DH (1991) Progress in the development of potent bombesin receptor antagonists. Trends Pharmacol Sci 12: 13–19
Johnson LR and Guthrie PD (1983) Regulation of antral gastrin content. Am J Physiol 245: G725–G729
Krane IM, Naylor SL, Helin-Davis D and Chin WW and Spindel ER . Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B (1988). J Biol Chem 263: 13317–13323
Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Pelyomäki P, Sistonen P, Aaltonen LA, Nyström-lahti M, Gua X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Warson P, Lynch HT, Trent JM, De La Chapelle A, Kinzler KW and Vogelstein B (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215–1225
McDonald TJ, Jörnvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR and Mutt V (1979) Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 90: 227–233
Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH and Jensen RT (1997). Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which
Minamino N, Kangawa K and Matsou H (1983) Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 114: 541–548
Narayan S, Guo Y-S, Townsend CM, Jr and Singh P (1990) Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res 50: 6772–6778
Naylor SL, Sakaguchi AY, Spindel E and Chin WW (1987) Human gastrin-releasing peptide gene is located on chromosome 18. Somat Cell Mol Genet 13 (1): 87–91
Preston SR, Ramsden CW, Miller GV and Primrose JN (1994) In vitro assay of bombesin and antagonists on human colon cancer cell line. Br J Surg 81: 1819
Preston SR, Woodhouse LF, Jones-Blackett S, Miller GV and Primrose JN (1995) High affinity binding sites for gastrin releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. Br J Cancer 71: 1087–1089
Preston SR, Miller GV and Primrose JN (1996) Bombesin-like prptides and cancer. Crit Rev Oncol Haematol 23 (3): 225–238
Price J, Penman E, Wass JAH and Rees LH (1984) Bombesin-like immunoreactivity in human gastrointestinal tract. Regul Pept 9: 1–6
Radulovic SS, Miller G and Schally AV (1991) Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 51: 6006–6009
Radulovic SS, Milanovanovic SR, Cai R-Z and Schally AV (1992) The binding of bombesin and somatostatin and their analogs to human colon cancers. P.S.E.M.B 200: 394–401
Rozengurt E and Sinnet-Smith J (1983) Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci USA 80: 2936–2940
Santen RJ, Manni A, Harvey H and Redmond C (1990) Endocrine treatment of breast cancer in women. Endocrine Reviews 11: 221–265
Sausville EA, Lebacq-Verheyden AM, Spindel ER, Cuttuta F, Gazdar AF and Battey JF (1986) Expression of the gastrin-releasing peptide gene in human small cell lung cancer. Evidence for alternative precessing resulting in three distinct mRNAs. J Biol Chem 261: 2451–2457
Schantz LJ, Naylor SL, Giladi E and Spindel ER (1991). Proceedings, 11th Annual Int. Human Gene Mapping Meeting. [Abstract]
Spindel ER, Chin WW, Price J, Rees LH, Besser GM and Habener JF (1984) Cloning and characterisation of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci USA 81: 5699–5703
Spindel ER, Zilderberg MD, Habener JF and Chin WW (1986) Two prohormones for gastrin-releasing peptide are encoded by two mRNAs differing by 19 bases. Proc Natl Acad Sci USA 83: 19–23
Spindel ER, Giladi E, Segerson TP and Nagalla S (1993) Bombesin-like peptides: of ligands and receptors. Recent Prog Horm Res 48: 365–391
Sunday ME, Kaplan LM, Motoyama E, Chin WW and Spindel ER (1988) Gastrin releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 59: 5–24
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL (1988) Genetic alterations during colorectal-tumour development. N Engl J Med 319: 525–532
Von Schrenck T, Heinz-Erain P, Moran T, Mantey SA, Gardener JD and Jensen RT (1989) Neuromedin B receptor in esophagus: evidence for receptor subtypes of bombesin receptors. Am J Physiol 256: G747–G758
Wang LH, Battey JF, Wada E, Lin JT, Mantey S, Coy DH and Jensen RT (1992) Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C6cells increases cellular Ca2+and phosphoinositides. Biochem J 286: 641–648
Wang LH, Mantey SA, Lin J-T, Frucht H and Jensen RT (1993) Ligand binding, internalization, degradation and regulation guanine nucleotides of bombesin receptor subtypes: a comparative study. Biochim Biophys Acta 1175: 232–242
Wang QJ, Knezetic JA, Schally AV, Pour PM and Adrian TE (1996) Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. Int J Cancer 68: 528–534
Weber S, Zuckermann JE, Bostwick DG, Bensch KG, Sikic BI and Raffin TA (1985) Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest 75: 306–309
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chave, H., Gough, A., Palmer, K. et al. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer 82, 124–130 (2000). https://doi.org/10.1054/bjoc.1998.0888
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1998.0888
Keywords
This article is cited by
-
Role of Ki‐67 Proliferation Index in the Assessment of Patients with Neuroendocrine Neoplasias Regarding the Stage of Disease
World Journal of Surgery (2014)
-
Gastrin-releasing peptide links stressor to cancer progression
Journal of Cancer Research and Clinical Oncology (2010)
-
Synergistic Regulation of COX-2 Expression by Bombesin and Transforming Growth Factor-β
Digestive Diseases and Sciences (2008)
-
Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies
Virchows Archiv (2006)
-
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
Oncogene (2001)